tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Is OBIO a Buy, Before Earnings?
PremiumPre-EarningsIs OBIO a Buy, Before Earnings?
3M ago
Orchestra BioMed Secures FDA Breakthrough Designation
Premium
Company Announcements
Orchestra BioMed Secures FDA Breakthrough Designation
3M ago
Orchestra BioMed price target lowered to $11 from $12 at Barclays
Premium
The Fly
Orchestra BioMed price target lowered to $11 from $12 at Barclays
3M ago
Orchestra BioMed, Terumo enter new $30M Virtue SAB agreements
PremiumThe FlyOrchestra BioMed, Terumo enter new $30M Virtue SAB agreements
4M ago
Orchestra Biomed’s New Study: A Game Changer in Coronary Treatment?
Premium
Company Announcements
Orchestra Biomed’s New Study: A Game Changer in Coronary Treatment?
4M ago
Orchestra BioMed announces first patient enrollments in Virtue SAB
Premium
The Fly
Orchestra BioMed announces first patient enrollments in Virtue SAB
4M ago
Orchestra BioMed downgraded to Neutral from Buy at BTIG
PremiumThe FlyOrchestra BioMed downgraded to Neutral from Buy at BTIG
6M ago
Orchestra BioMed Reports Q2 2025 Financial Results
Premium
Company Announcements
Orchestra BioMed Reports Q2 2025 Financial Results
6M ago
Orchestra BioMed announces publication of AVIM data in JACC
Premium
The Fly
Orchestra BioMed announces publication of AVIM data in JACC
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100